Skip to Content



Definition: A chimeric monoclonal antibody directed against the epidermal growth factor receptor used in the treatment of cancers of the lung, colon, rectum, and of the head and the neck.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.